BIOMAT Database Logo BIOMAT Database Logo

Optimal immunosuppression for HIV-positive kidney transplants: long-term randomized controlled trials needed. 2014

Susanna M Nazarian, and Elizabeth Ann Misch, and Robert M Rakita, and Ajit P Limaye
1 Division of Transplant Surgery Surgery, University of Washington Seattle, WA 2 Division of Allergy and Infectious Diseases Solid Organ Transplant Infectious Diseases Program, University of Washington Seattle, WA.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal

Related Publications

Susanna M Nazarian, and Elizabeth Ann Misch, and Robert M Rakita, and Ajit P Limaye
Kidney transplants and long-term immunosuppression.
October 1979, British medical journal,
Susanna M Nazarian, and Elizabeth Ann Misch, and Robert M Rakita, and Ajit P Limaye
Kidney transplants and long-term immunosuppression.
January 1980, British medical journal,
Susanna M Nazarian, and Elizabeth Ann Misch, and Robert M Rakita, and Ajit P Limaye
Kidney transplants and long-term immunosuppression.
September 1979, British medical journal,
Susanna M Nazarian, and Elizabeth Ann Misch, and Robert M Rakita, and Ajit P Limaye
Treatment. Kidney transplants available for HIV-positive.
January 2012, AIDS policy & law,
Susanna M Nazarian, and Elizabeth Ann Misch, and Robert M Rakita, and Ajit P Limaye
Randomized controlled trials are needed.
June 2008, Deutsches Arzteblatt international,
Susanna M Nazarian, and Elizabeth Ann Misch, and Robert M Rakita, and Ajit P Limaye
Platelet: RBC ratios: randomized controlled trials are needed for optimal resuscitation of injured patients.
December 2013, Critical care medicine,
Susanna M Nazarian, and Elizabeth Ann Misch, and Robert M Rakita, and Ajit P Limaye
Randomized controlled trials needed for bullous pemphigoid interventions.
February 2012, Archives of dermatology,
Susanna M Nazarian, and Elizabeth Ann Misch, and Robert M Rakita, and Ajit P Limaye
Long-term survival without immunosuppression in HIV-positive liver-graft recipient.
January 1991, Lancet (London, England),
Susanna M Nazarian, and Elizabeth Ann Misch, and Robert M Rakita, and Ajit P Limaye
Immunosuppression in HIV-positive kidney transplant recipients.
August 2023, Current opinion in organ transplantation,
Susanna M Nazarian, and Elizabeth Ann Misch, and Robert M Rakita, and Ajit P Limaye
Dual-kidney transplants: long-term results.
April 2003, Transplantation,
Copied contents to your clipboard!